Release date: 2017-03-21
Parkinson's disease is difficult to be diagnosed in time because of no specific symptoms in the early stage. When a patient's action disorder can be diagnosed, his nerve cells have been irreversibly destroyed, and the effect of drug treatment is quite limited. The neuroscientists at the University of Würzburg and the University of Marburg in Germany have made remarkable progress in this area. They have successfully found that skin tests can be used to confirm the hidden dangers of Parkinson's disease, which is many years before the diagnosis.
The scientists examined the skin of subjects with no Parkinson's symptoms and found alpha-synuclein specific to Parkinson's patients in their nerve endings. This protein, which is characteristic of Parkinson's disease, is no stranger to the industry, but it is often determined in the patient's brain after the patient has passed away. Now German scientists can diagnose Parkinson's disease by a small skin biopsy of five millimeters before or during the early stages of the disease, so that targeted and effective treatment can be performed before the patient's nerves are destroyed.
Source: Ministry of Science and Technology
Non-Locking Plate,Non-Locking Orthopedic Plate,Titanium Olecranon Plates,Humerus Distal Plates
Medton Medical , https://www.medtonmedical.com